Product & ReviewsAntibodies

PDL-1 Antibody

Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. PDL-1 is a B7-related protein that inhibits cell-mediated immune responses by reducing the secretion of IL-2 and IL-10 from memory T cells. This suggests that PDL-1 may be useful in reducing allogenic CD4+ memory T-cell responses to endothelial cells, thereby reducing the likelihood of host immune responses to allografts. At least two isoforms of PDL-1 are known to exist; this antibody is specific to the larger isoform. PDL-1 antibody has no cross-reactivity to PDL-2.

Product Details

Cat. No.
253699
Type
Primary Antibody
Clonality
Polyclonal
Host
Rabbit
Abbiotec

The supplier does not provide quotations for this antibody through SelectScience. You can search for similar antibodies in our  Antibody Directory.

Reviews

Average Rating 4.7

|2Scientists have reviewed this product

Specificity rating
Sensitivity rating
Quality rating
Write your own review

Performs well following the protocol.

 

Average Rating 5.0

Application Area:

Flow/IF/IHC

Excellent and thorough validation. Trustworthy vendor with great tech support.

Review Date: 28 Jan 2020 | Abbiotec

Performs reproducibly

 

Average Rating 4.3

Application Area:

Flow cytometry

Antibody specifically detects target in a variate of primary cell lines with different expression levels of the protein

Review Date: 1 Mar 2017 | Abbiotec

Applications

  • ELISA (ELISA)
  • Immunofluorescence (IF)
  • Immunohistochemistry (IHC)
  • Western Blotting (WB)

Antibody Overview

About the company

Abbiotec logo

Abbiotec

Abbiotec is a company focused on developing and commercializing next generation antibodies and reagents for the life science researchcommunity. Our approach and business concepts were born out of a need and our strong desire to deliver antibodies against druggable proteins. Our proprietary technologies allow us to select, design, and produce antibodies, lysates, and various reagents with a high degree of skill and efficiency so researchers can better focus their energies on their experimental designs and ideas.

4.6/5.0
|28 Reviews